News & Media

Larner College of Medicine in the Media

The following news and stories about LCOM appeared in local and/or national media.

  • Benzinga Reports on Conversation Lab Study of Psilocybin Cancer Therapy
    (AUGUST 25, 2023) Findings from a new study conducted by the University of Vermont’s Conversation Lab and therapeutics cancer firm Sunstone Therapies show the feasibility of trained human coders to identify observable markers of therapeutic connection during psilocybin administration within Psychedelic-Assisted Therapy (PAT), Benzinga reports.
    Read full story at Benzinga
  • Larner Researchers Find Lack of Confidence in Providers for Cannabis Info, Labroots Reports
    (AUGUST 18, 2023) In a study on medicinal cannabis use and reporting, Larner researchers Nicole Wershoven, Amanda Kennedy, Pharm.D., and Charles MacLean, M.D., found that just 18 percent of patients thought their provider was a “good source of information regarding cannabis” and cannabis-related health issues, according to Labroots.
    Read full story at Labroots
  • Heward Comments to WCAX about Integrated Addiction Treatment Approach at UVMMC
    (AUGUST 17, 2023) Brady Heward, M.D., assistant professor of psychiatry, spoke to WCAX-TV about an integrated approach by the University of Vermont Medical Center (UVMMC) to make addiction treatment more accessible.
    Read full story at WCAX-TV
  • Vermont Edition Interviews Plante about COVID Uptick, New Booster
    (AUGUST 17, 2023) Epidemiologist Timothy Plante ’06, M.D.’10, M.H.S., assistant professor of medicine, spoke with Vermont Public for a story focusing on the recent uptick in the number of COVID cases and a new, updated vaccine booster that is expected to be available in the fall.
    Read full story at Vermont Public
  • UVMMC Earns CMS 5-Star Quality Rating, Times Argus Reports
    (AUGUST 16, 2023) UVM Medical Center has again earned a 5-star quality rating from the Centers for Medicare & Medicaid Services (CMS), which announced its annual hospital ratings in late July, according to the Barre–Montpelier Times Argus.
    Read full story at The Barre–Montpelier Times Argus
  • Holmes Speaks to WCAX about New Study on Preventing Blood Clots in Cancer Patients
    (AUGUST 16, 2023) Hematologist Chris Holmes, M.D., Ph.D., professor of medicine, helped write a recent study that found an anticoagulant pill was just as effective as self-administered blood thinner injections at preventing deadly blood clots in cancer patients, according to WCAX-TV.
    Read full story at WCAX-TV
  • Larner Welcomes Class of 2027 Medical Students
    On August 7, 2023, the Larner College of Medicine at the University of Vermont welcomed 124 new medical students in the Class of 2027 to campus. Students in the Class of 2027 were selected from a pool of more than 8,500 applicants. Just over a quarter of the new med students are Vermonters and 24 percent identify as LGBTQ+. In addition, 24 percent of UVM’s newest medical students are people underrepresented in medicine—referred to in higher education as “URiM”—a category that includes African American/Black, Hispanic/Latino/a, and Native American/Alaskan Native. The student body draws from 26 states, excluding Vermont, and two Canadian provinces.
  • Khadanga Comments to In Profile Daily about Health Benefits of Walking
    (AUGUST 11, 2023) Sherrie Khadanga, M.D., assistant professor of medicine and director of cardiac rehabilitation at the University of Vermont Medical Center, commented to In Profile Daily on an article about the health benefits of walking.
    Read full story at In Profile Daily
  • Klemperer Study on Success of Prison Opioid Use Disorder Treatment Program Reported in VTDigger
    (AUGUST 10, 2023) A study led by principal investigator Elias Klemperer, Ph.D., assistant professor of psychology and psychiatry, found that Vermont’s medication program for incarcerated people with opioid use disorder has helped reduce overdoses after release, according to VTDigger.
    Read full story at VTDigger
  • Inside Precision Medicine Reports on Nelson Research into Vascular Dementia
    (AUGUST 8, 2023) Research by Mark Nelson, Ph.D., chair and University Distinguished Professor of pharmacology and professor of molecular physiology and biophysics, and colleagues shines a light on the mechanism behind vascular dementia in a mouse model, which the investigators hope will lead to better treatments being developed for the neurodegenerative condition, according to Inside Precision Medicine.
    Read full story at Inside Precision Medicine

Larner College of Medicine News

Recent news and stories from the college.

Media Relations

To schedule an interview with a faculty member, student, or staff member at the UVM Larner College of Medicine, contact: 

Angela Ferrante, Public Relations Manager
: (802) 656-3111
Mobile: (516) 458-0721